Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults

导出原文传递

翻译打印收藏纠错

作者： Che, Yanchun ^[1] ; Liu, Xiaoqiang ^[2] ; Pu, Yi ^[3] ; Zhou, Meijian ^[4] ; Zhao, Zhimei ^[5] ; Jiang, Ruiju ; Yin, Zhifang ; Xu, Mingjue ; Yin, Qiongzhou ; Wang, Jianfeng ; Pu, Jing ; Zhao, Heng ; Zhang, Ying ; Wang, Lichun ; Jiang, Ya ; Lei, Jin ; Zheng, Yan ; Liao, Yun ; Long, Runxiang ; Yu, Li ; Cui, Pingfang ; Yang, Huijuan ; Zhang, Yuehui ; Li, Jingyu ; Chen, Weiwu ; He, Zhanlong ; Ma, Kaili ; Hong, Chao ; Li, Dandan ; Jiang, Guorun ; Liu, Donglan ; Xu, Xingli ; Fan, Shengtao ; Cheng, Chen ; Zhao, Hongling ; Yang, Jianbo ; Li, Yan ; Zou, Yanxiang ; Zhu, Youshuai ; Zhou, Yaling ; Guo, Yingqiu ; Yang, Ting ; Chen, Hongbo ; Xie, Zhongping ; Li, Changgui ; Li, Qihan

作者单位： Yunnan Ctr Dis Control & Prevent ^[1] Mile Ctr Dis Control & Prevent ^[2] Natl Inst Food & Drug Control ^[3] Gejiu Ctr Dis Control & Prevent ^[4] Inst Med Biol,Chinese Acad Med Sci & Peking Union Med Coll ^[5]

关键词 inactivated SARS-CoV-2 vaccine phase 2 trial immunogenicity safety

发布时间 2022-03-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交